Merck looks to lower barriers to COVID-19 vaccination with oral approach

Though Merck trails COVID-19 vaccine front-runners, Roger Perlmutter believes that using oral delivery will add a route of administration to the growing armamentarium that could give greater accessibility, in particular for older people.

The pharma is also developing an oral antiviral that will begin pivotal testing in September...